VSTM Stock Analysis: Buy, Sell, or Hold?
VSTM - Verastem, Inc.
$6.10
-0.31 (-4.84%)
▼
5d:
-4.39%
30d:
-19.1%
90d:
-30.68%
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 19, 2026
Get Alerted When VSTM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: VSTM shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: VSTM shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: VSTM is currently trading at $6.10, which is considered oversold relative to its 30-day fair value range of $6.54 to $7.74.
Technical Outlook: Technically, VSTM is in a downtrend. The price is currently testing key support at $6.08. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.12 (+164.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VSTM is in a downtrend. The price is currently testing key support at $6.08. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.12 (+164.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$6.54 -
$7.74
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 164.3% below Wall St target ($16.12)
Fair Price Analysis
30-Day Fair Range
$6.54 -
$7.74
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$6.08
Resistance Level
$6.96
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.66
Wall Street Target
$16.13
(+164.3%)
Revenue Growth (YoY)
-78.6%
Last updated: February 02, 2026 8:23 AM ET
Data refreshes hourly during market hours. Next update: 9:23 AM
Data refreshes hourly during market hours. Next update: 9:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VSTM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Paul A Bunn
SELL
8333 shares
2025-10-09
Daniel Calkins
SELL
25 shares
2025-09-24
Daniel Calkins
SELL
57 shares
2025-09-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 53 HOLD |
Advanced VSTM Option Strategies
Professional options setups generated by AI based on today's VSTM price and gamma walls.
